These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1904053)

  • 21. GnRH agonist induces apoptosis in seminiferous tubules of immature rats: direct gonadal action.
    Peirouvi T; Salami S
    Andrologia; 2010 Aug; 42(4):231-5. PubMed ID: 20629645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of serum estradiol and leptin levels on thyroid function, food intake and body weight gain in female Wistar rats.
    Pantaleão TU; Mousovich F; Rosenthal D; Padrón AS; Carvalho DP; da Costa VM
    Steroids; 2010 Oct; 75(10):638-42. PubMed ID: 20363238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with buserelin, an agonist of gonadotropin-releasing hormone, suppresses ovarian hyperstimulation syndrome induced in rabbits.
    Oshima K; Suzuki K; Makita S; Yoshida Y
    Pharmacology; 2004 Nov; 72(3):184-9. PubMed ID: 15452367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective estrogen receptor modulator promotes weight loss in ovariectomized female rhesus monkeys (Macaca mulatta) by decreasing food intake and increasing activity.
    Sullivan EL; Shearin J; Koegler FH; Cameron JL
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E759-67. PubMed ID: 22252940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin.
    Pirard C; Donnez J; Loumaye E
    Hum Reprod; 2005 Jul; 20(7):1798-804. PubMed ID: 15890740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition.
    Goulding A; Gold E
    J Endocrinol; 1989 May; 121(2):293-8. PubMed ID: 2502594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of type I corticosteroid receptor in the effects of ovariectomy on energy balance.
    Dagnault A; Deshaies Y; Richard D
    Am J Physiol; 1996 Jan; 270(1 Pt 2):R199-206. PubMed ID: 8769803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats.
    del Mar Grasa M; Cabot C; Esteve M; Yubero P; Masanés RM; Blay MT; Vilà R; López-Martí J; Fernández-López JA; Remesar X; Alemany M
    Obes Res; 2001 Mar; 9(3):202-9. PubMed ID: 11323446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Continuous subcutaneous infusion of GnRH agonist: effective dosage in the treatment of endometriosis and its influence on the ovarian response to human menopausal gonadotropin].
    Masaoka K; Kitazawa M; Watanabe H; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):729-36. PubMed ID: 2504848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
    Mizutani T; Sakata M; Terakawa N
    Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy rates, LH and progesterone concentrations in mares treated with a GnRH agonist.
    Kanitz W; Schneider F; Hoppen HO; Unger C; Nürnberg G; Becker F
    Anim Reprod Sci; 2007 Jan; 97(1-2):55-62. PubMed ID: 16488561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stimulation of ovarian function with gonadotropins following suppression of endogenous gonadotropin secretion by long-term infusion of the LHRH analog buserelin].
    Geisthövel F; Bliefert R; Geyer H; Breckwoldt M; Sandow J
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):240-5. PubMed ID: 3109997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of post-mating GnRH analogue (buserelin) treatment on PGF2alpha release in ewes and ewe lambs.
    Khan TH; Beck NF; Mann GE; Khalid M
    Anim Reprod Sci; 2006 Sep; 95(1-2):107-15. PubMed ID: 16257149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buserelin-mediated osteoporosis: effects of restoring estrogen on bone resorption and whole body calcium content in the rat.
    Goulding A; Gold E
    Calcif Tissue Int; 1990 Jan; 46(1):14-9. PubMed ID: 2104770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
    Goulding A; Gold E; Feng W
    Bone Miner; 1992 Aug; 18(2):143-52. PubMed ID: 1525595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats.
    Wade GN; Heller HW
    Am J Physiol; 1993 Jun; 264(6 Pt 2):R1219-23. PubMed ID: 8322977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and functional consequences of buserelin-induced enteric neuropathy in rat.
    Sand E; Roth B; Weström B; Bonn P; Ekblad E; Ohlsson B
    BMC Gastroenterol; 2014 Dec; 14():209. PubMed ID: 25496312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of the alpha 2-adrenoceptor agonist, guanfacin, on energy expenditure, intake and deposition in rats.
    Gazzola C
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Sep; 112(1):29-34. PubMed ID: 8564787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.